Applicability of RPMI 2650 and Calu-3 Cell Models for Evaluation of Nasal Formulations
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14020369
Abstract: The RPMI 2650 and Calu-3 cell lines have been previously evaluated as models of the nasal and airway epithelial barrier, and they have demonstrated the potential to be used in drug permeation studies. However, limited… read more here.
Keywords: cell; 2650 calu; cell models; rpmi 2650 ... See more keywords